ASA: Cancer Risk Higher for Older Stroke Survivors

Share this content:
ASA: Cancer Risk Higher for Older Stroke Survivors
ASA: Cancer Risk Higher for Older Stroke Survivors

(HealthDay News) -- Older adults who survive a stroke may have a higher-than-average risk of developing cancer in the next few years, according to a study scheduled to be presented Thursday at the American Stroke Association's International Stroke Conference, held from Feb. 11 to 13 in Nashville, Tenn.

"We already knew that cancer patients are at increased risk of stroke. But what happens when you turn it around and look at cancer risks for ischemic stroke survivors? That was our question," Malik Adil, M.D., lead author from the research team at the Zeenat Qureshi Stroke Institute in St. Cloud, Minn., said in an association news release.

The research team analyzed data from the Vitamin Intervention for Stroke Prevention multicenter trial from 1997 to 2001. They calculated cancer rate differences between the stroke and non-stroke groups at one month, six months, one year, and two years, as well as the risk of death and other cardiovascular events. The findings were compared between stroke survivors who did and didn't develop cancer.

Over two years of follow-up, 2 percent of ischemic stroke survivors were newly diagnosed with a wide range of cancers, including skin, prostate, breast, lung, and bladder cancer. Stroke survivors over age 50 were 1.4 times more likely to develop cancer within two years than their counterparts who were age 50 and under.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »